A novel off-center paddle impeller (OPI) dissolution testing system for reproducible dissolution testing of solid dosage forms

Journal of Pharmaceutical Sciences

Volumn 101, Issue 2, 2012, Pages 746-760

  Wang, Yimin ^a   Armenante, Piero M ^a  

^a NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Dissolution; Dissolution rate; Mixing; Modified Apparatus 2; Off center impeller; Off center tablet; OPI dissolution testing apparatus; Solid dosage form; USP Apparatus 2

Indexed keywords

PREDNISONE; SALICYLIC ACID;

ARTICLE; DRUG DOSAGE FORM; DRUG SENSITIVITY; DRUG SOLUBILITY; IMPELLER; REPRODUCIBILITY; TABLET DISINTEGRATION;

EID: 84455205577     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22783     Document Type: Article

References (47)

1. The United States Pharmacopeia & The National Formulary. The Official Compendia of Standards, USP 34-NF 29. 2010. Rockville, Maryland: The United States Pharmacopeial Convention, Inc.
2. US Food and Drug Administration, Center for Drug Evalution and Research (CDER). 1997. Guidance for Industry-Dissolution Testing of Immediate Release Solid Oral Dosage Forms.
3. Cox DC, Furman WB. 1982. Systematic error associated with apparatus 2 of the USP dissolution test I: Effects of physical alignment of the dissolution apparatus. J Pharm Sci 71(4):451-452.
4. Cox DC, Furman WB, Thornton LK, Moore T W, Jefferson EH. 1983. Systematic error associated with apparatus 2 of the USP dissolution test III: Limitation of calibrators and the USP suitability test. J Pharm Sci 72(8):910-913.
5. Moore TW, Hamilton JF, Kerner CM. 1995. Dissolution testing: Limitations of the USP prednisone and salicylic acid calibrator tablets. Pharmacopeial Forum 21(5):1387-1396.
6. Qureshi SA, McGilveray IJ. 1999. Typical variability in drug dissolution testing: Study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product. Eur J Pharm Sci 7(3):249-258.
7. Costa P, Lobo JMS. 2001. Influence of dissolution medium agitation on release profiles of sustained-release tablets. Drug Dev Ind Pharm 27(8):811-817.
8. Qureshi SA, Shabnam J. 2001. Cause of high variability in drug dissolution testing and its impact on setting tolerances. Eur J Pharm Sci 12(3):271-276.
9. Mauger J, Ballard J, Brockson R, De S, Gray V, Robinson D. 2003. Intrinsic dissolution performance of USP dissolution apparatus 2 (rotating paddle) using modified salicylic acid calibrator tablets: Proof of principle. Dissolution Technol 10:6-15.
10. Gray V. 2006. Challenges to the dissolution test, including equipment calibration. Dissolution Technol 16(4):6-9.
11. Gray V, Kelly G, Xia M, Butler C, Thomas S, Mayock S. 2009. The science of USP 1 and 2 dissolution: Present challenges and future relevance. Pharm Res 26(6):1289-1302.
12. FDC Reports. 2001. Recalls prompted by FDA on the increase. The Gold Sheet 35:1.
13. FDC Reports. 2002. Counterfeits pose special recall challenge. The Gold Sheet 36:1.
14. FDC Reports. 2003. Spike in potency-related problems contributes to overall rise in 2002 recalls. The Gold Sheet 37:1.
15. US Food and Drug Administration, Department of Health and Human Services. 2009. FDA Enforcement Reports.
16. Bai G, Armenante PM. 2008. Velocity distribution and shear rate variability resulting from changes in the impeller location in the USP dissolution testing apparatus II. Pharm Res 25(2):320-336.
17. Bai G, Armenante PM. 2009. Hydrodynamic, mass transfer and dissolution effects induced by tablet location during dissolution testing. J Pharm Sci 98(4):1511-1531.
18. Bai G, Wang Y, Armenante PM. 2010. Velocity distribution and shear rate variability resulting from changes in the agitation speed in the USP apparatus II. Int J Pharm 403(1-2):1-14.
19. Bocanegra LM, Morris GJ, Jurewicz JT, Mauger JW. 1990. Fluid and particle laser Doppler velocity measurements and mass transfer predictions for the USP paddle method dissolution apparatus. Drug Dev Ind Pharm 16(9):1441-1464.
20. Kukura J, Arratia PC, Szalai ES, Muzzio FJ. 2003. Engineering tools for understanding hydrodynamics of dissolution tests. Drug Dev Ind Pharm 29:231-239.
21. McCarthy L, Kosiol C, Healy AM, Bradley G, Sexton J, Corrigan O. 2003. Simulating the hydrodynamic conditions in the United States Pharmacopeias paddle dissolution apparatus. AAPS PharmSciTech 4:E22.
22. Kukura J, Baxter JL, Muzzio FJ. 2004. Shear distribution and variability in the USP Apparatus 2 under turbulent conditions. Int J Pharm 279:9-17.
23. McCarthy L, Bradley G, Sexton G, Corrigan O, Healy AM. 2004. Computational fluid dynamics modeling of the paddle dissolution apparatus: Agitation rate mixing patterns and fluid velocities. AAPS PharmSciTech 5:50-59.
24. Bai G, Armenante PM, Plank RV, Gentzler M, Ford K, Harmon P. 2007. Hydrodynamic investigation of USP dissolution test apparatus II. J Pharm Sci 96(9):2327-2349.
25. Baxter JL, Kukura J, Muzzio FJ. 2005. Hydrodynamics-induced variability in the USP apparatus II dissolution test. Int J Pharm 292:17-28.
26. Baxter JL, Kukura J, Muzzio FJ. 2005. Shear-induced variability in the United States Pharmacopeia apparatus 2: Modifications to the existing system. AAPS J 7(4):E857-E864.
27. Bai G, Armenante PM, Plank RV. 2007. Experimental and computational determination of blend time in USP dissolution testing apparatus II. J Pharm Sci 96(11):3072-3086.
28. Scott P. 2005. Geometric irregularities common to the dissolution vessel. Dissolution Technol 12(1):18-21.
29. Tanaka M, Fujiwara H, Fujiwara M. 2005. Effect of the irregular inner shape of a glass vessel on prednisone dissolution results. Dissolution Technol 12(4):15-19.
30. Liddell MR, Deng G, Hauck WW, Brown WE, Wahab SZ, Manning RG. 2007. Evaluation of glass dissolution vessel dimensions and irregularities. Dissolution Technol 14(1):28-33.
31. Mirza T, Joshi Y, Liu Q, Vivilecchia R. 2005. Evaluation of dissolution hydrodynamics in the USP, Peak™ and flat-bottom vessels using different solubility drugs. Dissolution Technol 12(1):11-16.
32. Gao Z, Moore TW, Doub WH, Westenberger BJ, Bushe LF. 2006. Effect of deaeration methods on dissolution test in aqueous media: A study using a total dissolved gas pressure meter. J Pharm Sci 95(7):1606-1613.
33. Gao Z, Moore TW, Doub WH. 2008. Vibration effects on dissolution test with USP apparatus 1 and 2. J Pharm Sci 97(8):3335-3343.
34. Wells C. 1981. Effect of sampling probe on dissolution of tableted drug samples. J Pharm Sci 70(2):232-233.
35. Qureshi SA. 2004. A new crescent-shaped spindle for drug dissolution testing-But why a new spindle? Dissolution Technol 11(4):13-18.
36. Qureshi SA. 2006. Comparative impact of stirring and shearing in drug dissolution testing with USP paddle and crescent-shaped spindles. Dissolution Technol 13(1):25-30.
37. Spagnoli S, Di Maso M. 2006. A comparison of USP paddle with crescent-shaped spindle dissolution profiles. Dissolution Technol 13(3):25-30.
38. Beckett AH, Quach TT, Kurs GS. 1996. Improved hydrodynamics for USP apparatus 2. Dissolution Technol 3(2):7-12.
39. King PG. 1996. Altered dynamics for USP apparatus 2. Dissolution Technol 3(3):8-13.
40. Collins CC, Nair RR. 1998. Comparative evaluation of mixing dynamics in USP apparatus 2 using standard USP vessels and peak vessels. Dissolution Technol 5(2):7-18.
41. Moore TW. 1996. Dissolution testing: A fast, efficient procedure for degassing dissolution medium. Dissolution Technol 3(2):3-5.
42. Moore JW, Flanner HH. 1996. Mathematical comparison of dissolution profiles. Pharm Technol 20(6):64-74.
43. Oldshue JY. 1983. Fluid mixing technology. New York: McGraw-Hill, pp 1-20, 53-58.
44. Hemrajani RR, Tatterson GB. 2004. Mechanically stirred vessels. In Handbook of industrial mixing-Science and practice; Paul EL, Atiemo-Obeng VA, Kresta SM, Eds. New York: John Wiley & Sons, pp 345-390.
45. Armenante PM, Atiemo-Obeng V, Penney WR. 2005. Multiphase mixing and solid-liquid mixing in agitated reactors. In Encyclopedia of chemical processing; Sunggyu Lee, Ed. New York: Marcel Dekker, pp 1767-1779.
46. Atiemo-Obeng VA, Penney WR, Armenante PM. 2004. Solid-liquid mixing. In Handbook of industrial mixing-Science and practice; Paul EL, Atiemo-Obeng VA, Kresta SM, Eds. New York: John Wiley & Sons, pp 543-584.
47. Armenante PM, Wang Y. 2011. Novel dissolution testing system and apparatus with off-center impeller. Non-Provisional Patent US13086382.